On this page:OverviewKey papers
ScholarIQanswers from OpenAlex

Expert Review of Pharmacoeconomics & Outcomes Research

JournalCitation impact & published research

Expert Review of Pharmacoeconomics & Outcomes Research is a journal indexed in ScholarIQ from OpenAlex.

How many works does Expert Review of Pharmacoeconomics & Outcomes Research have?

ScholarIQindexed works

Expert Review of Pharmacoeconomics & Outcomes Research has 2,325 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Expert Review of Pharmacoeconomics & Outcomes Research have?

ScholarIQcitation count

Expert Review of Pharmacoeconomics & Outcomes Research has 38,360 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Expert Review of Pharmacoeconomics & Outcomes Research?

ScholarIQh-index

Expert Review of Pharmacoeconomics & Outcomes Research has an h-index of 81 in OpenAlex.

What is the OpenAlex record for Expert Review of Pharmacoeconomics & Outcomes Research?

ScholarIQopenalex

The OpenAlex for Expert Review of Pharmacoeconomics & Outcomes Research is on the source record.

What are the most-cited papers on Expert Review of Pharmacoeconomics & Outcomes Research?

ScholarIQmost cited works
Economic burden of healthcare-associated infections: an American perspective
Patricia W. Stone
Expert Review of Pharmacoeconomics & Outcomes Research. 2009394 CitationsOPEN ACCESS
Translation and back-translation methodology in health research – a critique
Uldis Ozoliņš, Sandra Hale, Xiang Cheng, Amelia Hyatt, Penelope Schofield
Expert Review of Pharmacoeconomics & Outcomes Research. 2020261 Citations
How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3)
BFM Wijnen, GAPG Van Mastrigt, Ken Redekop, HJM Majoie, R. de Kinderen, SMAA Evers
Expert Review of Pharmacoeconomics & Outcomes Research. 2016224 CitationsOPEN ACCESS
Direct and indirect cost of managing alzheimer’s disease and related dementias in the United States
Arijita Deb, J. Douglas Thornton, Usha Sambamoorthi, Kim E. Innes
Expert Review of Pharmacoeconomics & Outcomes Research. 2017193 CitationsOPEN ACCESS
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance
Brian Godman, Björn Wettermark, Mikael Hoffmann, Karolina Andersson Sundell, Alan Haycox, Lars L. Gustafsson
Expert Review of Pharmacoeconomics & Outcomes Research. 2009155 Citations

Related on ScholarIQ

470M+ articles · 14-day free trial